Birgit Schittek Selected Research

Birgit Schittek Research Topics

Disease

28	Melanoma (Melanoma, Malignant) 01/2022 - 04/2003
21	Neoplasms (Cancer) 11/2021 - 01/2004
9	Infections 03/2015 - 11/2002
7	Neoplasm Metastasis (Metastasis) 08/2020 - 04/2003
3	Staphylococcal Infections 01/2016 - 12/2009
2	Breast Neoplasms (Breast Cancer) 01/2018 - 07/2005
2	Skin Diseases (Skin Disease) 04/2016 - 09/2008
2	Carcinogenesis 10/2014 - 01/2011
2	Atopic Dermatitis (Atopic Eczema) 09/2008 - 06/2005
2	Pigmented Nevus (Melanocytic Nevus) 05/2007 - 01/2004
1	Triple Negative Breast Neoplasms 09/2020
1	Sepsis (Septicemia) 08/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2017
1	Brain Neoplasms (Brain Tumor) 12/2016
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 04/2016
1	Erectile Dysfunction 03/2016
1	Bacterial Infections (Bacterial Infection) 01/2016
1	Abscess 06/2015
1	Wounds and Injuries (Trauma) 01/2014
1	Inflammation (Inflammations) 01/2014
1	T-Cell Lymphoma (Lymphoma, T Cell) 02/2011
1	Leukemia 02/2011

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
5	VemurafenibIBA 01/2019 - 01/2013
5	Antimicrobial PeptidesIBA 09/2017 - 06/2005
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2017 - 09/2005
4	Protein Isoforms (Isoforms)IBA 11/2018 - 01/2004
4	Transcription Factors (Transcription Factor)IBA 04/2016 - 02/2011
3	Messenger RNA (mRNA)IBA 11/2021 - 12/2009
3	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 05/2007
3	Y-Box-Binding Protein 1IBA 01/2018 - 05/2007
3	CateninsIBA 06/2016 - 01/2011
3	Biological ProductsIBA 01/2016 - 01/2012
3	Mitogen-Activated Protein KinasesIBA 09/2015 - 02/2011
3	Peptides (Polypeptides)IBA 01/2014 - 09/2008
3	Cadherins (E-Cadherin)IBA 06/2012 - 09/2005
3	Adenosine Monophosphate (AMP)IBA 01/2011 - 09/2008
3	beta-DefensinsIBA 07/2010 - 09/2008
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2020
2	CalciumIBA 08/2020 - 01/2013
2	Phosphotransferases (Kinase)IBA 01/2019 - 01/2013
2	Antineoplastic Agents (Antineoplastics)IBA 12/2016 - 08/2006
2	Peptide Hydrolases (Proteases)FDA Link 04/2016 - 01/2016
2	LigandsIBA 03/2016 - 07/2004
2	Casein Kinases (Casein Kinase)IBA 01/2016 - 09/2010
2	dermcidinIBA 01/2012 - 06/2005
2	Sorafenib (BAY 43-9006)FDA Link 02/2011 - 08/2008
2	beta CateninIBA 01/2011 - 09/2010
2	Ribonuclease 7IBA 07/2010 - 12/2009
2	CathelicidinsIBA 09/2008 - 11/2002
2	Therapeutic UsesIBA 08/2008 - 08/2006
2	Integrin alphaVbeta3IBA 08/2006 - 09/2005
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 11/2021
1	Serine (L-Serine)FDA Link 09/2020
1	Adenosine Triphosphate (ATP)IBA 08/2020
1	Metalloproteases (Metalloproteinases)IBA 01/2019
1	NestinIBA 01/2019
1	PlatinumIBA 11/2018
1	Carboplatin (JM8)FDA LinkGeneric 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	Lipase (Acid Lipase)FDA Link 08/2018
1	AntibodiesIBA 09/2017
1	CytokinesIBA 09/2017
1	Anthralin (Dithranol)IBA 09/2017
1	Interleukin-17 (Interleukin 17)IBA 09/2017
1	Keratins (Keratin)IBA 09/2017
1	Interleukin-22 (IL-22)IBA 09/2017
1	trametinibIBA 05/2017
1	90-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 90 kDa)IBA 05/2017
1	Conditioned Culture MediaIBA 12/2016
1	NVP-BKM120IBA 12/2016
1	IonomycinIBA 04/2016
1	Antigen Receptors (Antigen Receptor)IBA 04/2016
1	Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA 04/2016
1	ZymosanIBA 04/2016
1	Sildenafil Citrate (Viagra)FDA Link 03/2016
1	Cyclic GMP-Dependent Protein Kinase Type IIBA 03/2016
1	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 03/2016
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 03/2016
1	atrial natriuretic factor receptor BIBA 03/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	lugduninIBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2016
1	Insulin (Novolin)FDA Link 09/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2015
1	Virulence Factors (Pathogenicity Factors)IBA 06/2015
1	Casein Kinase I (Casein Kinase 1)IBA 10/2014
1	Laminin (Merosin)IBA 01/2014
1	MicroRNAs (MicroRNA)IBA 03/2013
1	ThapsigarginIBA 01/2013
1	Proto-Oncogene Proteins B-rafIBA 01/2013
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 06/2012
1	CCAAT-Enhancer-Binding ProteinsIBA 02/2011
1	lonafarnib (SCH 66336)IBA 02/2011
1	TransferasesIBA 02/2011

Therapy/Procedure

12	Therapeutics 01/2022 - 06/2003
3	Drug Therapy (Chemotherapy) 11/2018 - 06/2009
1	Chemoradiotherapy 11/2021